JACC: CardioOncology - Predictive Performance of Cardiovascular Risk Scores in Cancer Survivors from the UK Biobank

In this podcast, Dr. Katrina Poppe reviews a study by Celeste McCracken and Dr. Zahra Raisi-Estabragh that evaluates the effectiveness of cardiovascular risk scores in cancer survivors using UK Biobank data. The research reveals that standard risk scores often underestimate cardiovascular risk in cancer survivors, particularly those with Hodgkin's lymphoma, hematological cancers, and brain malignancies, highlighting the need for tailored risk assessment tools for this population.